{"Title": "Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues", "Year": 2017, "Source": "Nucleic Acid Therape.", "Volume": "27", "Issue": 5, "Art.No": null, "PageStart": 251, "PageEnd": 259, "CitedBy": 66, "DOI": "10.1089/nat.2017.0682", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85030314866&origin=inward", "Abstract": "\u00a9 Copyright 2017, Mary Ann Liebert, Inc. 2017.Duchenne muscular dystrophy (DMD) is a rare, severe, progressive muscle-wasting disease leading to disability and premature death. Patients lack the muscle membrane-stabilizing protein dystrophin. Antisense oligonucleotide (AON)-mediated exon skipping is a therapeutic approach that aims to induce production of partially functional dystrophins. Recently, an AON targeting exon 51 became the first of its class to be approved by the United States regulators [Food and Drug Administration (FDA)] for the treatment of DMD. A unique aspect of the exon-skipping approach for DMD is that, depending on the size and location of the mutation, different exons need to be skipped. This challenge raises a number of questions regarding the development and regulatory approval of those individual compounds. In this study, we present a perspective on those questions, following a European stakeholder meeting involving academics, regulators, and representatives from industry and patient organizations, and in the light of the most recent scientific and regulatory experience.", "AuthorKeywords": ["exon skipping", "oligonucleotides", "regulatory approval"], "IndexKeywords": ["Animals", "Disease Models, Animal", "Drug Approval", "Dystrophin", "Exons", "Genetic Therapy", "Humans", "Mice", "Muscular Dystrophy, Duchenne", "Mutation", "Oligonucleotides, Antisense", "Stakeholder Participation", "United States", "United States Food and Drug Administration"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85030314866", "SubjectAreas": [["Biochemistry", "BIOC", "1303"], ["Molecular Medicine", "BIOC", "1313"], ["Molecular Biology", "BIOC", "1312"], ["Genetics", "BIOC", "1311"], ["Drug Discovery", "PHAR", "3002"]], "AuthorData": {"6506555410": {"Name": "Aartsma-Rus A.", "AuthorID": "6506555410", "AffiliationID": "60026712, 60006222", "AffiliationName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University"}, "7003355969": {"Name": "Straub V.", "AuthorID": "7003355969", "AffiliationID": "60026712, 60006222", "AffiliationName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University"}, "56242571300": {"Name": "Hemmings R.", "AuthorID": "56242571300", "AffiliationID": "60025465", "AffiliationName": "Medicines and Healthcare Product Regulatory Agency"}, "55326824500": {"Name": "Haas M.", "AuthorID": "55326824500", "AffiliationID": "60112036", "AffiliationName": "Central Nervous System and Ophthalmology, Scientific and Regulatory Management Department, Human Medicines Evaluation Division, European Medicines Agency"}, "6603327228": {"Name": "Balabanov P.", "AuthorID": "6603327228", "AffiliationID": "60112036", "AffiliationName": "Central Nervous System and Ophthalmology, Scientific and Regulatory Management Department, Human Medicines Evaluation Division, European Medicines Agency"}, "55507130200": {"Name": "Schlosser-Weber G.", "AuthorID": "55507130200", "AffiliationID": "100339196", "AffiliationName": "Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte"}, "36158887300": {"Name": "Stoyanova-Beninska V.", "AuthorID": "36158887300", "AffiliationID": "60113759", "AffiliationName": "Medicines Evaluation Board"}, "57211220608": {"Name": "Mercuri E.", "AuthorID": "57211220608", "AffiliationID": "60073799", "AffiliationName": "Centro Clinico Nemo, Policlinico Gemelli"}, "7102038246": {"Name": "Muntoni F.", "AuthorID": "7102038246", "AffiliationID": "60012662", "AffiliationName": "Dubowitz Neuromuscular Center, UCL Great Ormond Street Institute of Child Health"}, "6507271629": {"Name": "Sepodes B.", "AuthorID": "6507271629", "AffiliationID": "60016187, 60106051", "AffiliationName": "Faculdade de Farm\u00e1cia, Universidade de Lisboa"}, "6506812026": {"Name": "Vroom E.", "AuthorID": "6506812026", "AffiliationID": "116759499", "AffiliationName": "United Parent Project Muscular Dystrophy"}}}